These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9157451)

  • 1. [Physical therapy in patients with COPD and tracheobronchial instability--comparison of 2 oscillating PEP systems (RC-Cornet, VRP1 Desitin). Results of a randommized prospective study of 90 patients].
    Cegla UH; Bautz M; Fröde G; Werner T
    Pneumologie; 1997 Feb; 51(2):129-36. PubMed ID: 9157451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physiotherapy with oscillating PEP systems (RC-Cornet, VRP1) in COPD].
    Cegla UH
    Pneumologie; 2000 Oct; 54(10):440-6. PubMed ID: 11089396
    [No Abstract]   [Full Text] [Related]  

  • 3. [Course of Severe COPD with and without Physiotherapy with the RC-Cornet(R)].
    Cegla UH; Jost HJ; Harten A; Weber T; Wissmann S
    Pneumologie; 2002 Jul; 56(7):418-24. PubMed ID: 12140795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physical therapy with VRP1 in chronic obstructive respiratory tract diseases--results of a multicenter comparative study].
    Cegla UH; Retzow A
    Pneumologie; 1993 Nov; 47(11):636-9. PubMed ID: 8309924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physiotherapy in chronic obstructive pulmonary disease: oscillatory breathing with flutter VRP1].
    Weiner P; Zamir D; Waizman J; Weiner M
    Harefuah; 1996 Jul; 131(1-2):14-7, 71. PubMed ID: 8854470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of an oscillating physiotherapy device (RC-Cornet trade mark) on the regional distribution of the pulmonary aerosol deposition in patients with COPD].
    Haidl P; Rickert G; Cegla UH; Köhler D
    Pneumologie; 2002 Aug; 56(8):498-502. PubMed ID: 12174335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [RC-Cornet(R) improves the bronchodilating effect of Ipratropiumbromide (Atrovent(R)) inhalation in COPD-patients].
    Cegla UH; Jost JH; Harten A; Weber T
    Pneumologie; 2001 Oct; 55(10):465-9. PubMed ID: 11605121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flutter-VRP1 Desitin--a new physiotherapeutic device for the treatment of chronic obstructive bronchitis.
    Leru P; Bistriceanu G; Ibraim E; Stoicescu P
    Rom J Intern Med; 1994; 32(4):315-20. PubMed ID: 7613505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chest physiotherapy with positive airway pressure: a pilot study of short-term effects on sputum clearance in patients with cystic fibrosis and severe airway obstruction.
    Placidi G; Cornacchia M; Polese G; Zanolla L; Assael BM; Braggion C
    Respir Care; 2006 Oct; 51(10):1145-53. PubMed ID: 17005060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of physical therapy with VRP 1-Desitin ("Flutter")].
    Lindemann H
    Pneumologie; 1992 Dec; 46(12):626-30. PubMed ID: 1494580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effects of expiration under positive pressure in patients with acute exacerbation of chronic obstructive pulmonary disease and mild acidosis requiring non-invasive positive pressure ventilation.
    Bellone A; Spagnolatti L; Massobrio M; Bellei E; Vinciguerra R; Barbieri A; Iori E; Bendinelli S; Nava S
    Intensive Care Med; 2002 May; 28(5):581-5. PubMed ID: 12029406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Flutter VRP1: a new personal pocket therapeutic device used as an adjunct to drug therapy in the management of bronchial asthma.
    Girard JP; Terki N
    J Investig Allergol Clin Immunol; 1994; 4(1):23-7. PubMed ID: 8081537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of the FLUTTER VRP1 device for physiotherapy patients with chronic pulmonary disease].
    Lubiński W; Targowski T; Frank-Piskorska A
    Pol Merkur Lekarski; 2000 Jan; 7(43):37-40. PubMed ID: 10765651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive expiratory pressure (PEP) as lung physiotherapy in cystic fibrosis: a pilot study.
    Tønnesen P; Støvring S
    Eur J Respir Dis; 1984 Aug; 65(6):419-22. PubMed ID: 6381080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chest physiotherapy in hospitalized patients with cystic fibrosis: a study of lung function effects and sputum production.
    Oberwaldner B; Theissl B; Rucker A; Zach MS
    Eur Respir J; 1991 Feb; 4(2):152-8. PubMed ID: 2044730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of Flutter®VRP1 components on mucus transport of patients with bronchiectasis.
    Tambascio J; de Souza LT; Lisboa RM; Passarelli Rde C; de Souza HC; Gastaldi AC
    Respir Med; 2011 Sep; 105(9):1316-21. PubMed ID: 21641196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term treatment of chronic bronchitis with pulmonary physiotherapy with and without positive expiratory pressure].
    Christensen EF; Nedergaard T; Dahl R
    Ugeskr Laeger; 1991 Jan; 153(2):113-6. PubMed ID: 1989365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive expiratory pressure (PEP-mask) physiotherapy improves ventilation and reduces volume of trapped gas in cystic fibrosis.
    Groth S; Stafanger G; Dirksen H; Andersen JB; Falk M; Kelstrup M
    Bull Eur Physiopathol Respir; 1985; 21(4):339-43. PubMed ID: 3899222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physical therapy and mask treatment of chronic bronchitis and chronic obstructive lung disease (COPD)].
    Christensen HR; Viskum K; Kampmann JP
    Ugeskr Laeger; 1990 Oct; 152(44):3237-40. PubMed ID: 2238205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically ventilated patients: comparison of magnitude and duration of response.
    Duarte AG; Momii K; Bidani A
    Respir Care; 2000 Jul; 45(7):817-23. PubMed ID: 10926377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.